title: Cetuximab plus radiotherapy for head and neck cancer.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Cengiz
authors.forename: Ferah
authors.initials: F
authors.lastname: Yildiz
authors.forename: Mine
authors.initials: M
authors.lastname: Genc
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000532:radiotherapy*; D000068818:Cetuximab; D003131:Combined Modality Therapy; D003627:Data Interpretation, Statistical; D019583:Dose Fractionation, Radiation; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D009959:Oropharyngeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab